Hefei Hengxin Life Science and Technology
301501
SUNNY PERCISION
831906
Triductor Technology
688259
Zhejiang Sf Oilless Bearing Co.,Ltd.
300817
Jiangsu Apon Medical Technology
300753
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 28.04%1.79B | 15.01%1.15B | 17.89%519.63M | -23.35%1.51B | -6.21%1.4B | 2.56%998.7M | -4.39%440.79M | 69.95%1.97B | 58.44%1.49B | 74.77%973.77M |
Refunds of taxes and levies | 34.87%57.75M | 33.39%40.12M | -8.75%15.28M | -33.00%39.67M | -8.39%42.82M | -16.78%30.07M | 2.17%16.75M | -15.21%59.21M | 1.13%46.74M | 38.32%36.14M |
Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash received relating to other operating activities | -51.11%33.77M | -34.98%41.7M | -41.26%2.11M | -33.75%18.14M | 225.19%69.07M | 358.34%64.13M | -20.71%3.6M | 55.10%27.39M | 112.88%21.24M | 96.08%13.99M |
Cash inflows from operating activities | 24.61%1.88B | 12.58%1.23B | 16.46%537.03M | -23.76%1.57B | -3.12%1.51B | 6.74%1.09B | -4.32%461.14M | 64.97%2.06B | 56.32%1.56B | 73.41%1.02B |
Goods services cash paid | 67.39%1.44B | 59.85%979.67M | 32.07%437.52M | -41.27%802.72M | -21.99%862.27M | -21.38%612.87M | -14.99%331.28M | 9.19%1.37B | -0.35%1.11B | 16.74%779.55M |
Staff behalf paid | -0.93%179.21M | -2.84%121.43M | -12.10%68.92M | 10.26%184.14M | 42.00%180.88M | 32.75%124.98M | 27.65%78.41M | 13.17%167M | 13.93%127.38M | 19.75%94.14M |
All taxes paid | -6.50%60.52M | -9.47%40.57M | 101.75%15.89M | -11.87%76.43M | -11.16%64.73M | -0.12%44.82M | -45.75%7.88M | 148.51%86.72M | 169.44%72.86M | 166.86%44.87M |
Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash paid relating to other operating activities | 20.87%66.23M | 21.05%43.88M | 28.97%21.45M | -7.48%46.48M | 37.79%54.79M | 55.54%36.25M | 48.76%16.63M | 17.32%50.24M | 36.32%39.77M | 49.20%23.31M |
Cash outflows from operating activities | 50.45%1.75B | 44.77%1.19B | 25.24%543.78M | -33.57%1.11B | -13.58%1.16B | -13.05%818.91M | -8.94%434.2M | 13.12%1.67B | 5.33%1.35B | 20.94%941.86M |
Net cash flows from operating activities | -62.19%130.91M | -83.63%44.86M | -125.06%-6.75M | 18.55%459.22M | 63.22%346.2M | 234.01%274M | 423.85%26.94M | 268.82%387.36M | 175.50%212.11M | 143.55%82.03M |
Investing cash flow | ||||||||||
Cash received from returns on investments | ---- | ---- | ---- | --5.74M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --2.37K | ---- | --0 | ---- | ---- | ---- | --0 | -77.62%13.27K | 925.63%13.27K | ---- |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash received relating to other investing activities | -25.86%1.16B | -16.73%726.78M | 53.13%404.75M | 60.28%2.15B | 84.01%1.57B | 70.18%872.83M | -19.60%264.32M | 48.56%1.34B | -4.30%850.89M | -20.11%512.88M |
Cash inflows from investing activities | -25.86%1.16B | -16.73%726.78M | 53.13%404.75M | 60.70%2.16B | 84.01%1.57B | 70.18%872.83M | -19.60%264.32M | 48.55%1.34B | -4.30%850.9M | -20.11%512.88M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 16.80%98.99M | -42.37%40.2M | 66.18%20.56M | 60.67%39.59M | 308.47%84.75M | 759.99%69.76M | 154.98%12.37M | 6.07%24.64M | 25.32%20.75M | -34.21%8.11M |
Cash paid to acquire investments | ---- | ---- | 445.76%180.1M | 300.30%103.56M | 27.56%33M | 27.56%33M | --33M | 5,093.21%25.87M | 5,093.21%25.87M | 5,093.21%25.87M |
Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash paid relating to other investing activities | -27.43%1.15B | -39.88%553M | -28.51%265.24M | 65.95%2.3B | 85.82%1.59B | 81.80%919.87M | 102.94%371.03M | 62.29%1.38B | 0.03%853.19M | -23.45%505.97M |
Cash outflows from investing activities | -26.64%1.25B | -41.99%593.19M | 11.89%465.9M | 70.09%2.44B | 89.28%1.7B | 89.39%1.02B | 121.87%416.41M | 63.66%1.43B | 3.43%899.81M | -19.86%539.95M |
Net cash flows from investing activities | 35.48%-88.66M | 189.18%133.59M | 59.79%-61.15M | -210.14%-279.5M | -180.96%-137.41M | -453.28%-149.8M | -207.81%-152.09M | -416.54%-90.12M | -355.40%-48.91M | 14.75%-27.07M |
Financing cash flow | ||||||||||
Cash received from capital contributions | 1,471.68%126.65M | 1,204.10%59.15M | 25.90%3.13M | 111.19%14.31M | --8.06M | --4.54M | --2.49M | --6.78M | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --66.15M | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash from borrowing | 27.67%552.51M | 30.05%426.67M | -8.66%163.12M | 196.61%410.38M | 410.34%432.75M | 385.55%328.09M | 477.60%178.59M | -74.19%138.36M | -75.15%84.8M | -71.99%67.57M |
Cash received relating to other financing activities | ---- | ---- | --0 | --45.33K | --45.36K | --45.55K | --45.26K | ---- | ---- | ---- |
Cash inflows from financing activities | 54.05%679.16M | 46.04%485.82M | -8.21%166.25M | 192.66%424.73M | 419.90%440.86M | 392.33%332.67M | 485.79%181.12M | -72.93%145.13M | -75.15%84.8M | -71.99%67.57M |
Borrowing repayment | 29.81%378.91M | 12.69%248.45M | 167.25%91.27M | 7.13%394.6M | 16.45%291.9M | 12.79%220.47M | -64.84%34.15M | 22.28%368.32M | 19.15%250.67M | 44.74%195.46M |
Dividend interest payment | -33.46%82.15M | -36.69%76.86M | 137.50%1.58M | 99.40%124.07M | 100.69%123.47M | 101.38%121.42M | -51.61%664.62K | 9.21%62.22M | 10.10%61.52M | 8.76%60.29M |
-Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash payments relating to other financing activities | 4,665.42%267.87M | 7,227.07%266.11M | 4,511.34%73.97M | 24.23%7.19M | 34.13%5.62M | 23.44%3.63M | 18.05%1.6M | 10.69%5.79M | 98.45%4.19M | 31.39%2.94M |
Cash outflows from financing activities | 73.15%728.94M | 71.17%591.42M | 358.03%166.82M | 20.52%525.85M | 33.06%421M | 33.56%345.52M | -63.53%36.42M | 20.06%436.33M | 17.89%316.39M | 34.24%258.7M |
Net cash flows from financing activities | -350.64%-49.78M | -721.76%-105.61M | -100.40%-572.18K | 65.27%-101.12M | 108.58%19.86M | 93.28%-12.85M | 309.85%144.7M | -268.70%-291.2M | -417.82%-231.59M | -493.93%-191.13M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -391.01%-8.59M | -152.52%-4.02M | 140.13%1.63M | 104.63%390.27K | -63.68%2.95M | 216.03%7.65M | 116.48%678.01K | -354.08%-8.43M | 1,133.40%8.12M | 373.79%2.42M |
Net increase in cash and cash equivalents | -106.96%-16.12M | -42.17%68.82M | -430.60%-66.85M | 3,408.73%79M | 484.29%231.6M | 188.97%119M | -72.36%20.22M | 90.47%-2.39M | 68.23%-60.27M | 22.45%-133.75M |
Add:Begin period cash and cash equivalents | 36.71%376.92M | 36.71%376.92M | 36.71%376.92M | -0.95%248.12M | 10.06%275.7M | 10.06%275.7M | 10.06%275.7M | -9.09%250.51M | -9.09%250.51M | -9.09%250.51M |
End period cash equivalent | -28.88%360.79M | 12.93%445.73M | 4.78%310.07M | 31.84%327.12M | 166.66%507.31M | 238.04%394.7M | -8.57%295.92M | -0.95%248.12M | 121.63%190.24M | 13.27%116.76M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.